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Background: Rhinella schneideri, previously known as Bufo paracnemis, is a common toad in many regions of Brazil.
Its venom exerts important cardiovascular effects on humans and other animals. Although this toad venom has
been the subject of intense investigations, little is known about its neuromuscular activity.
Methods: The neurotoxicity of a methanolic extract of R. schneideri venom was tested on mouse phrenic
nerve-diaphragm (PND) preparations mounted for conventional twitch tension recording – in response to indirect
stimulation – and for electrophysiological measurements.
Results: Venom extract (50 μg/mL) increased the muscle twitch tension in PND preparations but did not significantly
alter the resting membrane potential values. Electrophysiological evaluations showed that the extract (50 μg/mL)
significantly augmented the frequency of miniature end-plate potential (from 38 ± 3.5 to 88 ± 15 after 60 minutes; n = 5;
p < 0.05) and quantal content (from 128 ± 13 to 272 ± 34 after five minutes; n = 5; p < 0.05). Pretreatment with ouabain
(1 μg/mL) for five minutes prevented the increase in quantal content (117 ± 18 and 154 ± 33 after five and 60 minutes,
respectively).
Conclusion: These results indicate that the methanolic extract of R. schneideri venom acts primarily presynaptically to
enhance neurotransmitter release in mouse phrenic-diaphragm preparations.
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Amphibians produce cutaneous secretions that serve as a
defense against predators [1]. Toads in particular have
highly toxic venom that is produced by well-developed
postorbital parotid glands [2]. The cardiovascular effects of
toad venom on vertebrates are well known and have been
extensively investigated, particularly in the genus Rhinella
[3,4]. The main venom toxins responsible for its cardiac ef-
fects are bufadienolides and bufotoxins that increase car-
diac contractility and decrease cardiac rate by inhibiting the
Na+/K+-ATPase pump in a manner similar to digoxin [3,4].
In contrast, little is known about the neuromuscular activity
of toad venoms, although it was previously observed that
envenoming in dogs may be accompanied by neurological* Correspondence: sandrorostelato@yahoo.com.br
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article, unless otherwise stated.manifestations such as mydriasis, nystagmus and opisthot-
onus [5].
Rhinella schneideri (formerly known as Bufo paracnemis
Lutz, 1925) is a common toad in several South American
countries [6]. A previous study observed that rats injected
intraperitoneally with R. schneideri venom (2–5 mg) show
uncoordinated movements, dyspnea, convulsions and par-
alysis, followed by respiratory and cardiac arrest [7]. This
sequence of events indicates that in rats neurotoxic mani-
festations precede cardiac effects, an order that is peculiar
to this venom. In the present work, we examined the
neurotoxicity of a methanolic extract obtained from Brazil-
ian R. schneideri venom on mouse neuromuscular prepara-
tions in vitro.Methods
Venom was collected by manual compression of large
postorbital parotid glands from two toads. An amount ofd Central Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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days at room temperature, after which the resulting ex-
tract was lyophilized in a SpeedVac® centrifuge (Savant,
USA) [8]. The methanolic extract was lyophilized and
dissolved in Tyrode solution prior to testing on neuro-
muscular preparations.
Male Swiss white mice (25–30 g) were obtained from
the Multidisciplinary Center for Biological Investigation
(CEMIB/UNICAMP). The animals were housed at 23 ±
3°C on a 12-hour light/dark cycle with free access to food
and water.
The diaphragm and its phrenic nerve were dissected from
male Swiss mice killed with isoflurane (Cristália, Brazil).
The preparations were mounted under a resting tension of
5 g in a 5 mL organ bath containing aerated (95% O2 and
5% CO2) Tyrode solution (composition, in mM: NaCl 137,
KCl 2.7, CaCl2 1.8, MgCl2 0.49, NaH2PO4 0.42, NaHCO3
11.9 and glucose 11.1) at 37°C, as described by Bülbring [9].
Supramaximal stimuli (0.1 Hz and 0.2 ms for indirect
stimulation) were delivered from a Grass S88 stimulator
(Grass Instrument Co., USA) and the muscle twitches were
recorded using a Load Cell BG-25 g force displacement
transducer coupled to a Gould RS 3400 recorder (both
from Gould Inc., USA). The preparations were allowed to
stabilize for at least 20 minutes before the addition of meth-
anolic extract (50 μg/mL).
End-plate potentials (EPPs), miniature end-plate po-
tentials (MEPPs) and resting membrane potentials (RPs)
were measured with a high input impedance electrom-
eter (World Precision 750, USA) in mouse diaphragm
muscle preparations using conventional microelectrode
techniques. The dissected muscle was mounted in a
lucite chamber containing aerated (95% O2 and 5% CO2)
Tyrode solution (pH 7.4, at room temperature of 23-27°C)
with or without methanolic extract (50 μg/mL). Intracellu-
lar microelectrodes filled with 3 M KCl (resistance 15–25
MΩ) were used. The EPPs, MEPPs and muscle RPs were
recorded on an oscilloscope (Tektronix, USA) and subse-
quently documented as described below. The RP recordings
were taken at the end-plate regions in the absence or pres-
ence of methanolic extract at t0 (basal), t5, t15, t30 and t60
minutes.
EPPs were recorded in muscles previously subjected to
the cut muscle technique in order to uncouple muscle con-
tractions from nerve stimulation. [10]. A direct-current
channel was used to record the RPs and an alternate-
current channel was used to record the EPPs. The EPPs
were magnified (AM 502 Tektronix amplifier, gain ¼ 100),
low-pass filtered (3 kHz) and digitized (15 kHz sampling
rate) using an analog-to-digital converter (Lynx, Brazil;
CAD12/36, resolution: 12 bits) coupled to a microcom-
puter (Microtec, Brazil) loaded with AqDados 5 software
(Lynx) that enabled digital storage of the EPPs online and
their subsequent retrieval for measurement and analysis.For measurement of the quantal content of EPPs, a
stimulus rate of 1 Hz for one minute was generated at t0
(basal), t5, t15, t30 and t60 minutes and 30 to 60 potentials
were measured at each interval. The quantal content (QC)
was estimated as the quotient between the squared average
of the EPPs and the variance of the EPPs (indirect method),
as described by Dal Belo et al. [11].
MEPPs were recorded in uncut muscle without gener-
ating electric stimuli. MEPP measurements were ob-
tained before (t0) and at various intervals (t5, t15, t30
and t60) after methanolic extract addition.
Each experimental protocol was repeated 3 to 8 times
and the results were reported as the mean ± S.E.M. Stu-
dent’s t-test and repeated-measures analysis of variance
(ANOVA) were used for statistical comparison of the
data, with a value of p < 0.05 indicating significance. All
data analyses were done using OriginPro 8.
Results and discussion
The methanolic extract (50 μg/mL) produced an increase
in muscle twitch tension in PND preparations (Figure 1)
during a 120-minute observation. There was little concen-
tration dependence in this effect since the responses at
lower (25 μg/mL) and higher (200 μg/mL) concentrations
of extract were not significantly different from those ob-
served with 50 μg/mL (data not shown).
The methanolic extract (50 μg/mL) significantly in-
creased the frequency of MEPPs from 38 ± 3.5/minute
(control) to 88 ± 15/minute after 60 minutes (Figure 2A),
without affecting the amplitude of these potentials (data
not shown). Incubation with extract resulted in a signifi-
cant increase in the quantal content within five minutes
followed by a gradual decrease towards basal (control)
values over the next 60 minutes, although the level after
60 minutes was still significantly greater than the control
(Figure 2B). Pretreatment of the preparations with a non-
toxic concentration of ouabain (1 μg/mL), an inhibitor of
Na+/K+-ATPase pump activity, for five minutes prior to
incubation with the methanolic extract prevented the in-
crease in quantal content (Figure 2B), although ouabain
alone had no effect on this parameter [12].
Incubation with the methanolic extract (50 μg/mL) did
not affect the resting membrane potential of the prepa-
rations [81 ± 0.9 mV (control) vs. 78 ± 0.9 mV after 60-
minute incubation with extract].
Rostelato-Ferreira et al. [13] employed the methanolic ex-
tract (3–30 μg/mL) on chick biventer cervicis preparations
and observed a concentration-dependent neuromuscular
blockade that was preceded by significant facilitation of
neurotransmission at 10 μg/mL. However, this response
was not accompanied by alterations in muscle contractures
to exogenous ACh or KCl, indicating that the extract had
no inhibitory effect on postsynaptic nicotinic receptors and
neither interfere with the muscle contracture mechanism.
Figure 1 Neuromuscular activity of methanolic extract of R. schneideri in vertebrate nerve–muscle preparations. (A) Neuromuscular
response produced by methanolic extract in indirectly stimulated mouse PND preparations. (B) Individual myographic record. Note the facilitatory
response without neuromuscular blockade. (W, wash; Bar: 5 g). The points represent the mean ± S.E.M. of 5–6 experiments. *p < 0.05 compared to
the twitch-tension at time 0.
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tract from R. schneideri venom contains substances capable
of affecting neurotransmission in PND preparations. The
extract caused sustained muscle facilitation that apparently
resulted from enhanced presynaptic neurotransmitter re-
lease since electrophysiological measurements indicated an
increase in MEPP frequency; such a response is generally
associated with a facilitatory effect on neuromuscular trans-
mission [14,15]. In contrast, variations (increase or de-
crease) in MEPP amplitude – such as those that occur with
curare and anticholinesterase drugs – are indicative of a
postsynaptic action [16]. The absence of these variations in
PND preparations incubated with the extract suggested that
there was no postsynaptic action involved. Further evidence
for a presynaptic involvement was the marked increase
in quantal content within five minutes after the extract
addition to the preparations. Dal Belo et al. [11] observed a
similar increase in the quantal content of PND preparations
after ten-minute incubation with MiDCA1, a toxin isolated
from coral snake (Micrurus dumerilli carinicauda) venom,
and concluded that a presynaptic action was involved.
Digoxin, a cardiac glycoside, and ouabain, a cardiotonic
steroid derivative structurally similar to digoxin, potentiatecardiac contractions by inhibiting the Na+-K+-ATPase
pump in cardiomyocytes which, in turn, leads to the accu-
mulation of intracellular calcium through indirect blockade
of the Na+/Ca2+ antiport system. Low concentrations of
these substances facilitate the spontaneous and evoked re-
lease of acetylcholine, thereby increasing the frequency of
MEPPs, the amplitude of single end-plate potentials and
their quantum content [17,18].
Toad venoms are highly cardiotoxic and exert their cardi-
otoxicity by a digoxin-like effect [19,20]. Marinobufagenin,
an extensively studied component of Rhinella marina
(previously Bufo marinus), is a specific inhibitor of
Na+-K+-ATPase that acts through the cardiac glycoside
binding site of this pump [21]. The experiments with oua-
bain described herein showed that the presynaptic effect of
the methanolic extract was associated with the inhibition of
Na+-K+-ATPase since preincubation with ouabain prevented
the release of acetylcholine (increase in quantal content) in
mouse PND preparations.
Previous reports have demonstrated that the quantal
release of neurotransmitters from nerve terminals may
be controlled by a ouabain-sensitive mechanism not dir-
ectly related to the pump function of Na+-K+-ATPase
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Figure 2 Electrofisiological measurements in PND preparations. (A) Changes in the frequency of miniature end-plate potentials (MEPPs) in
phrenic nerve-diaphragm preparations incubated with a methanolic extract of R. schneideri venom (50 μg/mL). Insets I and II in A: recordings at
time zero (0) and after incubation with extract for 60 minutes, respectively. (B) Changes in the quantal content (end-plate potentials) of phrenic
nerve-diaphragm preparations incubated with a methanolic extract of R. schneideri venom (50 μg/mL) for up to 60 minutes and the effect of
pretreatment with ouabain (1 μg/mL). The columns are the mean ± S.E.M. (n = 5), *p < 0.05 compared to control preparations.
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Na+-K+-ATPase apparently plays an important role in the
frequency-dependent modulation of the quantum release
of neurotransmitters [12]. Our experiments showed that
the presynaptic effect of the extract was inhibited by a non-
toxic concentration of ouabain (1 μM). While this finding
suggests the involvement of Na+-K+-ATPase in this pre-
synaptic action, the experimental protocol used here does
not exclude the possibility of a non-specific interaction be-
tween ouabain and components of the methanolic extract.Albeit the blockade of the Na+ pump by a non-toxic con-
centration of ouabain (1 μM) is insufficient to impair the
intracellular ionic homeostasis at low frequencies of stimu-
lation, and the precise role of the Na+-K+-ATPase pump in
the cholinergic modulation of presynaptic functions is still
unclear [23]. Krivoi [24] suggested that activation of the
Na+-K+ electrogenic pump could hyperpolarize nerve
endings, thereby decreasing repolarization of the K+ current
in presynaptic spikes and weakening the inactivation of
sodium channels.
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In conclusion, our results suggest that the methanolic ex-
tract of R. schneideri venom acts primarily presynaptically
to enhance neurotransmitter release in mouse phrenic-
diaphragm preparations and these effects were prevented
through the inhibition of neuronal Na+-K+-ATPase.
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